碧水源(300070.SZ):控股股東擁有公司表決權股份比例被動減少達到1%
格隆匯7月23日丨碧水源(300070.SZ)公佈,公司於近日收到股東王雪芹女士、陳亦力先生分別出具的《關於股份減持的吿知函》,收到控股股東中國城鄉控股集團有限公司(以下簡稱"中國城鄉")出具的《關於履行信息披露義務的吿知函》。因王雪芹女士、陳亦力先生存在部分表決權委託給控股股東中國城鄉的情形,本次王雪芹女士共減持28,253,300股,其中涉及表決權委託部分14,876,069股;陳亦力先生共減持22,406,267股,其中涉及表決權委託部分21,400,330股。兩人合計減持的股份導致中國城鄉所擁有公司表決權股份被動減少36,276,399股,佔公司總股本的1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.